TipRanks
KOREA UNITED PHARM, INC. (KR:033270)
:033270
South Korea Market
033270
KOREA UNITED PHARM, INC.
RESEARCH TOOLSreports

KOREA UNITED PHARM, INC. (033270) Income Statement

― Followers

KOREA UNITED PHARM, INC. Income Statement

Last quarter (Q2 2026), KOREA UNITED PHARM, INC.'s total revenue was ₩77.22B, an increase of 9.73% from the same quarter last year. In Q2, KOREA UNITED PHARM, INC.'s net income was ₩37.71B. See KOREA UNITED PHARM, INC.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
₩ 288.76B₩ 288.71B₩ 278.94B₩ 262.52B₩ 221.04B
Gross Profit
₩ 175.41B₩ 163.97B₩ 158.98B₩ 145.29B₩ 122.66B
Operating Expenses
₩ 126.50B₩ 107.68B₩ 104.03B₩ 97.07B₩ 89.43B
Depreciation and Amortization
₩ 11.56B₩ 11.27B₩ 10.09B₩ 8.71B₩ 7.39B
EBITDA
₩ 60.47B₩ 57.84B₩ 70.78B₩ 61.77B₩ 46.61B
Operating Income
₩ 48.91B₩ 56.28B₩ 54.95B₩ 48.21B₩ 33.23B
Other Income/Expenses
₩ 911.52M₩ -10.19B₩ 5.13B₩ 5.21B₩ 5.50B
Pretax Income
₩ 49.82B₩ 46.09B₩ 60.08B₩ 53.42B₩ 39.48B
Net Income
₩ 38.31B₩ 32.45B₩ 48.26B₩ 45.28B₩ 28.65B
Per Share Metrics
Basic EPS
₩ 2.61K₩ 2.21K₩ 3.30K₩ 3.06K₩ 1.93K
Diluted EPS
₩ 2.61K₩ 2.21K₩ 3.28K₩ 3.04K₩ 1.92K
Weighted Average Shares Outstanding
 16.33M 14.69M 14.63M 14.81M 14.84M
Weighted Average Shares Outstanding (Diluted)
 16.33M 14.73M 14.73M 14.90M 14.94M
Currency in KRW

KOREA UNITED PHARM, INC. Earnings and Revenue History